Breast cancer cells are effectively purged from peripheral blood progenitor cells with an immunomagnetic technique

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 81-86

  Tyer, Christy L ^a   Vredenburgh, James J ^a   Heimer, Martha ^a   Peters, William P ^a   Bast Jr , Robert C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ARTICLE; BLOOD; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CELL SEPARATION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; TUMOR CELLS, CULTURED;

EID: 0030051725     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. International Advisory Committee for the Autologous Bone Marrow Transplant Registry. Bone marrow autotransplantation in man: report of an international cooperative study. Lancet 2: 960-962, 1986.
2. Spitzer, G., Valdiveeso, M., Farha, P., Dicke, K. S., Murphy, W. K , Dhingra, H. M., Chiuten, D. F., Umsawasdi, T., Vellekoop, L., and Zander, A. R. High-dose chemotherapy with autologous bone marrow support in limited small cell bronchogenic carcinoma. In: K. Dicke, G. Spitzer, and A Zander (eds.), The First International Symposium on Autologous Bone Marrow Transplantation, pp. 155-160 Houston: The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, 1985.
3. Biron, P., Phillip, T., Maraninchi, D., Pico, J. L., Cahn, J. Y., Fumoleau, P., LeMevel, A., Gastaut, J A., Carcassonne, M., Kamioner, D., Herve, P., Brunat-Mentigny, M., and Hayat, M. Massive chemotherapy and autologous bone marrow transplantation in progressive disease of nonseminomatous testicular cancer. A phase II study of 15 patients. In: K. Dicke, G. Spitzer, and A. Zander (eds ), The First International Symposium on Autologous Bone Marrow Transplantation, pp 203-210. Houston. The University of Texas M. D. Anderson Hospital and Tumor Institute of Houston, 1985
4. Antman, K., and Gale, R. P. Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants. Ann. Intern. Med., 108: 570-574, 1988.
5. Jones, R. B., Shpall, E, J., Shogan, J , Moore, J., Gockerman, J., and Peters, W. AFM induction chemotherapy followed by intensive consolidation with autologous bone marrow (ABM) support for advanced breast cancer. Proc. Am. Soc. Clin Oncol., 7: 8, 1988.
6. Peters, W. P., Rosner, G., Ross, M., Vredenburgh, J., Meisenberg, B., Gilbert, C., and Kurtzberg, J. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood, 81: 1709-1719, 1993.
7. Sheridan, W. P., Begley, C. G., Juttner, C. A., Szer, J., To, L. B., Maher, D., McGrath, K. M., Morstyn, G., and Fox, R. M. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet. 339: 640-644, 1992.
8. Kessinger, A., Armitage, J. O., Landmark, J. D., Smith, D. M., and Weisenburger, D. D. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood, 71: 723-727, 1988.
9. Juttner, C. A., To, L. B., Ho, J. Q K., Bardy, P. G., Dyson, P. G., Haylock, D. N., and Kimber, R. J. Early lymphohemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant. Proc., 20: 40-43, 1988.
10. Redding, H., Monaghan, P., Ormerod, M., Gazet, J., Coombes, R., Clink, H., Dearnaley, D., Sloane, J., Powles, T., and Neville, A. Detection of micrometastases in patients with primary breast cancer. Lancet, 2: 1271-1273, 1983.
11. Porro, G., Mennard, S., Tagliabue, E., Orefice, S., Salvadori, B., Squicciarini, P., Andreola, S., Rilke, F., and Colnaghi, M. Monoclonal antibody detection of carcinoma cells in bone marrow biopsy specimens from breast cancer patients. Cancer (Phila.), 61: 2407-2411, 1988.
12. Smith, I. Recurrent disease. In: J. R. Harris (ed.). Breast Diseases, pp. 369-384. Philadelphia: J. B. Lippincott Co., 1987.
13. Buzdar, A. U. Natural history of stage IV breast cancer. In: K. Dicke, G. Spitzer, and A. Zander (eds.), The First International Symposium on Autologous Bone Marrow Transplantation, pp. 185-188. Houston: The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, 1985.
14. Anderson, I. C., Shpall, E. J., Leslie, D. S., Nustad, K., Ugelstad, J., Peters, W. P., and Bast, R. C., Jr. Elimination of malignant clonogenic breast cancer cells from human bone marrow. Cancer Res., 49: 4659-4664, 1989.
15. Ross, A., Cooper, B. W., Lazarus, H. M., Mackay, W., Moss, T. J., Clobanu, N., Tollman, M. S., Kennedy, M. J , Davidson, N., Sweet, D., Winter, C., Akard, L., Jansen, J., Copelan, E., Meagher, R C., Herzig, R. H., Klumpp, T. R., Kahn, D. G., and Warner, N. E. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood, 82: 2605-2610, 1993.
16. Hartmann, O., Benhamou, E., Beaujean, F., Kalifa, C., Lejars, O., Patte, C., Behard, C., Flamant, F., Thyss, A , Deville, A., Vannier, J. P., Pautard-Muchemble, B., and Lemerle, J. Repeated high-dose chemotherapy followed by purged autologous bone marrow transplantation as consolidation therapy in metastatic neuroblastoma. J. Clin. Oncol. 5: 1205-1211, 1987.
17. Morecki, S., Pavlotzky, F., Margel, S., and Slavin, S. Purging breast cancer cells in preparation for autologous bone marrow transplantation. Bone Marrow Transplant., 1: 357-363, 1987.
18. Coombes, R. C., Buckman, R., Forrester, J A., Shepherd, V., O'Hare, M. J., Vincent, M., Powles, T. J., and Neville, A. M. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer. Cancer Res., 46: 4217-4220, 1986.
19. Bregni, M , DeFabrities, P., Raso, V., Greenberger, J., Lipton, J., Nadler, L., Rothstein, L., Ritz, J., and Bast, R. C., Jr. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody-ricin A chain conjugates. Cancer Res., 46: 1208-1213, 1986.
20. O'Briant, K. C., Shpall, E. J., Houston, L. L., Peters, W. P , and Bast, R. C., Jr. Elimination of clonogenic breast cancer cells from human bone marrow: a comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres. Cancer (Phila.), 68: 1272-1278, 1991.
21. Bast, R. C., Jr., Ritz, J., Lipton, J. M., Gelber, R., Maver, C., Nadler, L., Sallan, S., and Ritz, J. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res., 43: 1389-1394, 1983.
22. Bast, R, C., Jr., DeFabrities, P., Lipton, J., Gelber, R., Maver, C., Nadler, L., Sallan, S., and Ritz, J. Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Cancer Res., 45: 499-503, 1985.
23. Gee, A. P., Van Hilten, J., Graham-Pole, J., and Boyle, M. D. Antibody-complement killing of neuroblastoma cells. Prog. Clin. Biol. Res., 175: 471-483, 1985.
24. Reynolds, C. P., Seeger, R. C., Vo, D. D., Black, A. T., Wells, J., and Ugelstad, J. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res., 46: 5882-5886, 1986.
25. Boyle, M. D., and Gee, A. P. Low antigen density tumor cells: an obstacle to effective autologous bone marrow purging? Cancer Invest., 5: 113-118, 1987.
26. Fogh, J., Wright, W. C., and Loveless, J. D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst., 58: 209-214, 1977.
27. Lasfargues, E. Y., Coutinho, W. G., and Redfield, E. S. Isolation of two human tumor epithelial cell lines from solid breast carcinomas. J. Natl Cancer Inst., 61: 967-973, 1978.
28. Fogh, J., and Trampe, G. New human tumor cell lines. In: J. Fogh (ed). Human Tumor Cells In Vitro. pp. 115-153. New York: Plenum Press, 1975.
29. Boyer, C. M., Borowitz, M. J , McCarty, K. S., Jr., Kinney, R. B., Everitt, L., Dawson, D. V., Ring, D., and Bast, R. C., Jr. Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells. Int. J. Cancer, 43: 55-60, 1989.
30. Leslie, D. S., Johnson, W. W., Daly, L., Ring, D. B., Shpall, E. J., Peters, W. P., and Bast, R. C., Jr. Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. Am. J. Clin. Pathol., 94: 8-13, 1990.
31. Ugelstad, J., Berge, A , Ellingsen, T., Aune, O., Kilaas, L., Nilsen, T. N., Schmid, R., Stenstad, P., Funderud, S., Kvalheim, G., Nustad, K., Lea, T., Vandal, F., and Danielsen, H. Monosized magnetic particles and their use in selective cell separation. Makromol. Chem., 17: 177-211, 1988.
32. Haleem, A., Kurtzberg, J., Olsen, G. A., Leslie, D. S., Ray, L., Smith, C. A , Rhinehardt-Clark, A., Peters, W. P., Haynes, B. F., and Bast, R. C., Jr. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2′-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement. Cancer Res., 47: 4608-4612, 1987.
33. Vredenburgh, J. J., Simpson, W., Memoli, V. A., and Ball, E. D. Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads. Cancer Res., 57: 2451-2455. 1991.
34. Vredenburgh, J. J.. and Ball, E. D. Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads Cancer Res., 50: 7216-7220, 1990.
35. Johnston, E., and Brown, W. B. The Spearman estimator for serial dilution assays. Biometrics, 30: 79-88, 1961.
36. Kies, M. S., Gordon, L. I., Rosen, S. T., Kucuk, O., and Vriesendorp, H. M. Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation. J. Exp. Hematol. (NY), 16: 190-194, 1988.
37. Tondini, C., Pap, S. A., Hayes, D. F , Elias, A. D., and Kufe, D. W. Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow. Cancer Res., 50: 1170-1175, 1990.
38. Vredenburgh, J., Shpall, E. J., Ross, M , Meisenberg, B., Bast, R. C., Jr., Tyer, C., Tepperberg, M., Eggleston, S., and Peters, W. P. Immunopharmacologic bone marrow purging and high-dose chemotherapy with autologous bone marrow support (ABMS) for patients with metastatic breast cancer. Proc. Am. Soc. Clin. Oncol., 11: 58a, 1992.
39. Tyer, C. L., DeSombre K, Vredenburgh, J. J., Peters, W. P., and Bast RC. Two-color immunofluorescence tumor cell detection in immunomagnetically purged stage IV breast samples. J. Hematother., 4: 245, 1995.
40. Vredenburgh, J. J., Ross, M., Meisenberg, B., Hussein, A., Kurtzberg, J., Gilbert, C., Petros, W., and Peters, W. P. A short course of G-CSF for priming of peripheral blood progenitor cells (PBPC) (Abstract). Blood, 80: 291a, 1992.
41. Feeney, M., Knapp, R., Greenberger, J., and Bast, R. C., Jr. Elimination of leukemic cells from rat bone marrow using antibody and complement. Cancer Res., 41: 3331-3335, 1981.
42. Gee, A. P., VanHilten, J., Graham-Pole, J., and Boyle, M. Antibody complement killing of neuroblastoma cells. Prog. Clin. Biol. Res., 78: 29-34, 1985.
43. Gee, A. P., Bruce, K. M., VanHilten, J., Sidnen, E. J., Braylan, R. C., Bauer, P. C., and Boyle, M. D. P. Selective loss of expression of a tumor-associated antigen on a human leukemia cell line induced by treatment with monoclonal antibody and complement. J. Natl. Cancer Inst., 78: 29-35, 1987.
44. Gee, A., Bruce, K., Morris, T., and Boyle, M. Evidence of an anti-complementary factor associated with human bone marrow cells. J. Natl. Cancer Inst., 75: 441-445, 1985.
45. Malpas, J. S., Kemshead, J. T., Pritchard, J., and Greaves, M. F. Variability in surface antigen expression on neuroblastoma cells as revealed by monoclonal antibodies. In. C. Raybaud, R. Clement, G. Lebreuil, and J. L. Bernard (eds.), Pediatric Oncology. Proceedings of the X11th Meeting of the International Society of Pediatric Oncology. Marseilles, Sept. 15-19, 1981, pp. 90-95. Amsterdam: Excerpta Medica, 1981.
46. Gee, A., Lee, C., Bruce, K., Janssen, J., Graham-Pole, J., Pawlina, T., Pick, T., Harvey, W., Koch, P., and Gross, S. Immunomagnetic purging and autologous transplantation in stage D neuroblastoma. In: A. Gee and S. Gross (eds.), Proceedings of the First International Workshop on Bone Marrow Purging, Orlando, FL, pp. 89-93 New York: Scientific and Medical MacMillan Press, 1987
47. Kvalheim, G., Sorensen, O., Fodstad, O., Funderrud, S., Kiesel, S., Dorken, B., Nustad, K., Jakobsen, E., Ugelstad, J., and Pihl, A. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use. Bone Marrow Transplant., 3: 31-41, 1988.
48. Vartdal, F., Kualheim, G., Lea, T. E., Bosnes, V., Gaudernack, G., Ugelstad, J., and Albrechtsen, D. Depletion of T lymphocytes from human hone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies. Transplantation, 43: 366-371, 1987.
49. Gorin, N C. Marrow purging: present status and future perspectives - efficacy in AML (Review) Prog. Clin. Biol. Res., 377: 251-263, 1992.
50. Gribben, J. G., and Nadler, L. M. Detection of minimal residual disease in patients with lymphomas using the polymerase chain reaction (Review). Important Adv. Oncol., 117-129, 1994.
51. Vredenburgh, J. J., Silva, O., deSombre, K., Franklin, W., Cirrincione, C., Berry, D., Peters, W. P., and Bast, R. C., Jr. The significance of bone marrow micrometastases for patients with breast cancer and ≥10+ lymph nodes treated with high dose chemotherapy and hematopoietic support. Proc. Am. Soc. Clin. Oncol. Annu. Meet., 14: 317, 1995.
52. Vredenburgh, J. J., Waters-Pick, B., Kurtzberg, J., Drago, S., Ross, M., Hussein, A., and Peters, W. P. A single 6-hour (HR) steady state leukapheresis is sufficient for collection of peripheral blood progenitor cells (PBPC) after G-CSF (Abstract). Blood, 82: 1381a, 1993.
53. Pettengell, R., Morgenstern, G. R., Woll, P. J., Chang, J , Rowlands, M., Young, R., Radford, J. A , Scarffe, J. H., Testa, N. G., and Crowther, D. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood, 82: 3770-3777, 1993.
54. Passos-Coelho, J. L., Ross, A. A., Moss, T. J., Davis, J. M., Huelskamp, A. M., Noga, S. J., Davidson, N. E., and Kennedy, M. J. Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood, 85: 1138-1143, 1995.
55. Rill, D. R., Santana, V M., Roberts, W. M., Nilson, T., Bowman, L. C., Krance, R. A., Heslop, H. E., Moen, R. C., Ihle, J. N., and Brenner, M. K. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood, 84: 380-383, 1994.